Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052

Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced that it has formed a strategic alliance with IntelligentNano Inc. and, as a result of the alliance, the two groups have created a water soluble nano-formulation of Quest's SL052 technology, which has the potential to address a wider range of clinical needs than Quest's current formulation of SL052.

Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052

Edmonton, Alberta, Canada | Posted on March 19th, 2009

"We have successfully used nanoparticles to make SL052 water soluble while maintaining the biological activity of the drug, whether activated by light or ultrasound," said Dr. Jie Chen, Chief Technology Officer for IntelligentNano, a spin-off company from the Canadian National Research Council's National Institute for Nanotechnology.

"The fulfillment of a second tier of targetable, water-soluble nano-formulations of the SonoLight compounds represents major progress in the adaptation of Hypocrellin-based photodynamic and sonodynamic therapy to a wide spectrum of clinical needs including cancer treatment," stated Dr. Madi R. Madiyalakan, Chief Executive Officer at Quest.

The alliance between Quest and IntelligentNano was forged to explore the potential of nanotechnology to provide a multiplicity of biocompatible drug delivery systems for clinical applications of Quest's proprietary SonoLight technology platform. Current SonoLight photosensitizer and sonosensitizer formulations are based upon liposomal drug delivery systems which target the drug to the desired sites of photodynamic or sonodynamic therapies. Quest intends to initiate a series of preclinical studies with these new formulations and arrive at a clinical plan for Quest's second cancer indication.

The results from the product development initiative will be presented at the prestigious Institute of Electrical and Electronics Engineers, Inc. National Institute of Health conference (IEEE/NIH) to be held on April 9, 2009 at the National Institute of Health in Maryland, USA.

The strategic alliance between Quest and IntelligentNano was made possible by financial and strategic support from the National Research Council's Industrial Research Assistance Program (NRC-IRAP).

Quest also announced today that it has received a one-year extension for the repayment of its $500,000 convertible debenture. The repayment of the debenture, which is exercisable at $0.25 per common share, was originally due on March 22, 2009. Payment is now due on March 22, 2010.


About Quest PharmaTech Inc.
Quest is a publicly traded, Alberta-based pharmaceutical company committed to the development and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cancer and dermatological conditions based on its unique photodynamic and sonodynamic therapy platforms.

About the SonoLight Platform

SL017 and SL052 represent members of Quest's SonoLight Portfolio with the potential to reduce or eliminate the side effects associated with currently available cancer treatment modalities: surgery, chemotherapy and radiotherapy. Their properties of activation with harmless physical agents (light or ultrasound), combined with their ability to generate cancer vaccines and stimulate an anti-cancer immune response, warrant further development in a broad-spectrum oncology arena. Quest intends to initiate a Phase I trial to evaluate SL052 as a localized treatment for prostate cancer. Development of second generation drug delivery systems provides greater flexibility with regards to treatment of a wide variety of diseases throughout the body.

About IntelligentNano Inc.

IntelligentNano is a private company, founded by Dr. Jie Chen and Dr. James Xing from the University of Alberta, with a mandate to harness the burgeoning potential of nanotechnology and convert it into practical benefits
to the field of medicine and pharmaceuticals.

Dr. Madi R. Madiyalakan
Chief Executive Officer
Quest PharmaTech Inc.
Tel: (780) 448-1400 Ext. 204

Media and Investor Relations
Adam Peeler
The Equicom Group Inc.
Tel: (416) 815-0700 Ext. 225

Copyright © Quest PharmaTech Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Graphene Canada 2015: Conference program revealed featuring the latest developments on graphene October 6th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement to Provide Its Technology to Google, NASA and USRA's Quantum Artificial Intelligence Lab October 6th, 2015

Global Engineering Firm DPS to Establish U.S. Advanced Technology Group Headquarters at SUNY Poly CNSE and Create 56 New Jobs Under STARTUP-NY Initiative October 6th, 2015

Electron tomography with 3,487 images in 3.5 seconds: High-speed electron tomography sets new standards for 3-D images of the nanoworld October 6th, 2015


Nanofilm Introduces Clarity AR Lens Cleaner for Anti-Reflective Superhydrophobic Lenses August 20th, 2015

Pixelligent Launches New PixClear® Light Extraction Materials for OLED Lighting August 4th, 2015

Aculon Launches NanoProof Series for PCB Waterproofing July 20th, 2015

Philips Introduces Quantum Dot TV with Color IQ™ Technology from QD Vision: Manufacturer is first to offer quantum dot displays for both TVs and monitors June 30th, 2015


Observing the unobservable: Researchers measure electron orbitals of molecules in 3-D October 6th, 2015

Superconductivity trained to promote magnetization: Russian scientist and her colleagues discovered the superconductivity effect, which will help to create future supercomputers October 6th, 2015

Nanoscale photodetector shows promise to improve the capacity of photonic circuits: Researchers at the University of Rochester have fabricated a device in which light can induce a current using a silver nanowire -- an important step toward harnessing light to speed up the next ge October 6th, 2015

Big range of behaviors for tiny graphene pores: Like biological channels, graphene pores are selective for certain types of ions October 6th, 2015

Personal Care

Nanofilm Introduces Clarity AR Lens Cleaner for Anti-Reflective Superhydrophobic Lenses August 20th, 2015

Sediment dwelling creatures at risk from nanoparticles in common household products August 13th, 2015

Engineering a better 'Do: Purdue researchers are learning how August 4th, 2015

Proving nanoparticles in sunscreen products August 4th, 2015

Alliances/Trade associations/Partnerships/Distributorships

SUNY Poly Announces Joint Development Agreement with INFICON to Establish Cutting Edge R&D Partnership Supporting New York State’s Rapidly Expanding Nanoelectronics Industry September 23rd, 2015

Pushing the limits of lensless imaging: At the Frontiers in Optics conference researchers will describe a custom-built ultrafast laser that could help image everything from semiconductor chips to cells in real time September 21st, 2015

Nanotech expertise earns Virginia Tech a spot in National Science Foundation network: New center's focus will be on earth, environmental nanotechnology September 16th, 2015

Graphene Enhanced ARALDITE Resin Composite Materials September 14th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic